An update from Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) is now available.
Zylox-Tonbridge Medical Technology Co., Ltd. has announced a change in its principal place of business in Hong Kong, effective January 10, 2025. This strategic decision may facilitate enhanced operations and presence in the Hong Kong market, potentially impacting the company’s business dynamics and stakeholder engagement.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a medical technology company incorporated in the People’s Republic of China. The company operates in the medical industry, focusing on developing and providing innovative medical solutions.
YTD Price Performance: -1.54%
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €450.1M
For an in-depth examination of 2190 stock, go to TipRanks’ Stock Analysis page.